About 70 results
Open links in new tab
  1. Lumryz: Uses, Dosage, Side Effects & Warnings - Drugs.com

    Oct 30, 2024 · Lumryz (sodium oxybate) is used for the treatment of patients with narcolepsy. Includes Lumryz side effects, interactions and indications.

  2. LUMRYZ is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy (1). DOSAGE AND ADMINISTRATION . Dosing...

  3. LUMRYZ™ (sodium oxybate) | For Patients

    For the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults and children 7 years of age and older with narcolepsy. LUMRYZ is proven to treat the daytime symptoms of cataplexy or …

  4. LUMRYZ™ (sodium oxybate) for extended-release oral suspension (CIII ...

    INDICATIONS AND USAGE LUMRYZ (sodium oxybate) for extended-release oral suspension is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime …

  5. Lumryz: Uses, Side Effects, Dosage, Cost, and More - Healthline

    Oct 16, 2025 · What is Lumryz used for? Lumryz is used to help manage certain symptoms of narcolepsy. Specifically, Lumryz helps treat excessive daytime sleepiness (EDS) or cataplexy.

  6. Lumryz (Avadel CNS Pharmaceuticals, LLC): FDA Package Insert

    Dec 4, 2025 · Avadel CNS Pharmaceuticals, LLC: LUMRYZ is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older...

  7. Lumryz (Sodium Oxybate for Extended-release Oral Suspension ... - RxList

    Jan 21, 2025 · Drug Summary What Is Lumryz? Lumryz (sodium oxybate) is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults …

  8. FDA Label for Lumryz For Suspension, Extended Release Oral ...

    Jan 16, 2026 · LUMRYZ is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. The recommended starting dosage is 4.5 grams (g) once per night …

  9. Lumryz (sodium oxybate) - Food and Drug Administration

    LUMRYZ is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy (1). Initiate dosage at 4.5 g once per night...

  10. • LUMRYZ is the sodium salt of gamma-hydroxybutyrate (GHB). Abuse or misuse of illicit GHB is associated with CNS adverse reactions, including seizure, respiratory depression, decreased …